48th Annual Meeting
June 24-28, 2012
Philadelphia, PA
Pennsylvania Convention Center
Collaborative Partnerships in Drug Development: A CRO CEO Roundtable Discussion
Tuesday, June 26, 20121:30–3:30 pm
Hear from top executives as they share their vision for the future of pharmaceutical development.
• What will it look like in five years, and how do we get there?
• What trends do we see?
• Have we seen the end of risk- and equity-sharing models in partnering?
• What are the pressures of private versus public ownership?
Moderator
Ed Silverman
Editor, Pharmalot
UBM, US
Ed Silverman
Editor, Pharmalot
UBM, US
Paula Brown Stafford
President, Clinical
Development,
Quintiles, US
President, Clinical
Development,
Quintiles, US
Jeffrey P. McMullen
President and CEO,
PharmaNet/i3, an inVentiv
Health Company, US
President and CEO,
PharmaNet/i3, an inVentiv
Health Company, US
Douglas J. Peddicord, PhDExecutive Director,
Association of Clinical
Research Organizations, US
Association of Clinical
Research Organizations, US
Josef von Rickenbach, MBA
Chairman and CEO,
PAREXEL International, US
Chairman and CEO,
PAREXEL International, US
William J. Sharbaugh, MA, MScCOO, PPD, Inc., US
John WatsonChief Commercial Officer, Corporate Senior Vice President
and President of Strategic Partnering,
Covance
and President of Strategic Partnering,
Covance
No comments:
Post a Comment